8-K
File 001-36407
FORM 8-K
- Filing date
- 06 Jun 2017
- Reporting date
- 06 Jun 2017
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
ALNYLAM PHARMACEUTICALS, INC. reports
- Company location
- Cambridge, MA
- Fiscal year end
- 31 December
Company
Names, identifiers, and filing context for this profile.
1 identity field
SEC filing record 1 source field available
ALNYLAM PHARMACEUTICALS, INC. has filed 1,677 SEC EDGAR filings since 09 Jul 2002
SEC filing history
Showing 776-800 of 1,000 matching filings.
Per page
25
Current page
32
4
FORM 4 SUBMISSION
- Filing date
- 01 Jun 2017
- Reporting date
- 31 May 2017
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
PRIMARY DOCUMENT
- Filing date
- 31 May 2017
- Reporting date
- 30 May 2017
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
PRIMARY DOCUMENT
- Filing date
- 25 May 2017
- Reporting date
- 23 May 2017
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
424B5
File 333-217688
424B5
- Filing date
- 25 May 2017
- Reporting date
- Not listed
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
8-K
File 001-36407
8-K
- Filing date
- 25 May 2017
- Reporting date
- 23 May 2017
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
424B5
File 333-217688
424B5
- Filing date
- 23 May 2017
- Reporting date
- Not listed
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
PRIMARY DOCUMENT
- Filing date
- 17 May 2017
- Reporting date
- 16 May 2017
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
PRIMARY DOCUMENT
- Filing date
- 17 May 2017
- Reporting date
- 15 May 2017
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
3
PRIMARY DOCUMENT
- Filing date
- 09 May 2017
- Reporting date
- 09 May 2017
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
8-K
File 001-36407
FORM 8-K
- Filing date
- 09 May 2017
- Reporting date
- 08 May 2017
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
S-3ASR
File 333-217688
S-3ASR
- Filing date
- 05 May 2017
- Reporting date
- Not listed
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
10-Q
File 001-36407
10-Q
- Filing date
- 05 May 2017
- Reporting date
- 31 Mar 2017
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing
8-K
File 001-36407
ALNYLAM PHARMACEUTICALS, INC. 8-K
- Filing date
- 05 May 2017
- Reporting date
- 02 May 2017
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
DEF 14A
File 001-36407
DEFINITIVE PROXY STATEMENT
- Filing date
- 17 Mar 2017
- Reporting date
- 02 May 2017
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
10-K
File 001-36407
10-K
- Filing date
- 15 Feb 2017
- Reporting date
- 31 Dec 2016
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing
SC 13G/A
File 005-79884
SCHEDULE 13G AMENDMENT NO. 1
- Filing date
- 14 Feb 2017
- Reporting date
- Not listed
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
SC 13G/A
File 005-79884
SC 13G/A filing
- Filing date
- 14 Feb 2017
- Reporting date
- Not listed
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
SC 13G/A
SC 13G/A
- Filing date
- 13 Feb 2017
- Reporting date
- Not listed
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
SC 13G/A
File 005-79884
SC 13G/A filing
- Filing date
- 13 Feb 2017
- Reporting date
- Not listed
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
SC 13G/A
File 005-79884
SEC SCHEDULE 13G
- Filing date
- 09 Feb 2017
- Reporting date
- Not listed
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
SC 13G/A
File 005-79884
SC 13G/A filing
- Filing date
- 09 Feb 2017
- Reporting date
- Not listed
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
8-K
File 001-36407
ALNYLAM PHARMACEUTICALS, INC. 8-K
- Filing date
- 08 Feb 2017
- Reporting date
- 08 Feb 2017
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
CT ORDER
File 001-36407
CT ORDER filing
- Filing date
- 07 Feb 2017
- Reporting date
- Not listed
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
PRIMARY DOCUMENT
- Filing date
- 03 Feb 2017
- Reporting date
- 01 Feb 2017
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing